PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29663378-6 2018 Cultured human SCS calvarial cells treated with Crizotinib exhibited a dose-dependent decrease in alkaline phosphatase activity and mineral deposition, with an associated decrease in expression levels of Runt-related transcription factor 2 and OSTEOPONTIN, with reduced PI3K/Akt signalling in vitro. Crizotinib 48-58 RUNX family transcription factor 2 Homo sapiens 204-239